Company Description
Decision Diagnos (OTC Link: DECN) is classified in the pharmaceutical retailers industry within the Healthcare sector and carries a market capitalization of $35.8K.
DECN has gained 0.0% over the past year. Shares last traded at $0.0000.
This page collects what Stock Titan holds for DECN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Decision Diagnos (DECN) stock last traded at $0.0000. Over the past 12 months, the stock has gained 0.0%. At a market capitalization of $35.8K, DECN is classified as a micro-cap stock with approximately 141.6M shares outstanding.
Latest News
Decision Diagnos has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include covid-19, fda approval. View all DECN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Decision Diagnos (DECN) currently stands at 100 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Decision Diagnos (DECN) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
DECN Company Profile & Sector Positioning
Decision Diagnos (DECN) operates in the Pharmaceutical Retailers industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing DECN often look at related companies in the same sector, including Allstar Health Brands Inc (ALST), Health Advance I (HADV), Pineapple (PNPL), Blum Holdings (BLMH), and Healthwarehouse (HEWA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate DECN's relative position within its industry.